PDB Short entry for 5FXS HEADER TRANSFERASE 02-MAR-16 5FXS TITLE IGFR-1R COMPLEX WITH A PYRIMIDINE INHIBITOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE, UNP RESIDUES 980-1286; COMPND 5 SYNONYM: INSULIN-LIKE GROWTH FACTOR I RECEPTOR, IGF-I RECEPTOR, IGFR- COMPND 6 1R; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.DEGORCE,S.BOYD,J.CURWEN,R.DUCRAY,C.HALSALL,C.JONES,F.LACH,E.LENZ, AUTHOR 2 M.PASS,S.PASS,C.TRIGWELL,R.NORMAN,C.PHILLIPS REVDAT 4 08-MAY-24 5FXS 1 REMARK REVDAT 3 11-JUL-18 5FXS 1 JRNL REVDAT 2 16-MAY-18 5FXS 1 JRNL REVDAT 1 19-OCT-16 5FXS 0 JRNL AUTH S.L.DEGORCE,S.BOYD,J.O.CURWEN,R.DUCRAY,C.T.HALSALL, JRNL AUTH 2 C.D.JONES,F.LACH,E.M.LENZ,M.PASS,S.PASS,C.TRIGWELL JRNL TITL DISCOVERY OF A POTENT, SELECTIVE, ORALLY BIOAVAILABLE, AND JRNL TITL 2 EFFICACIOUS NOVEL 2-(PYRAZOL-4-YLAMINO)-PYRIMIDINE INHIBITOR JRNL TITL 3 OF THE INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR (IGF-1R). JRNL REF J. MED. CHEM. V. 59 4859 2016 JRNL REFN ISSN 1520-4804 JRNL PMID 27078757 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00203 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0090 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 25378 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1342 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1874 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.95 REMARK 3 BIN R VALUE (WORKING SET) : 0.1950 REMARK 3 BIN FREE R VALUE SET COUNT : 87 REMARK 3 BIN FREE R VALUE : 0.2310 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2358 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 274 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.48000 REMARK 3 B22 (A**2) : -0.05000 REMARK 3 B33 (A**2) : -0.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.150 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.130 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.080 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.150 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.929 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2517 ; 0.007 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 1690 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3419 ; 1.097 ; 1.960 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4110 ; 0.969 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 320 ; 5.490 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 100 ;33.275 ;23.100 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 410 ;11.318 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;12.086 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 369 ; 0.063 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2864 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 535 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1574 ; 0.461 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 631 ; 0.076 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2527 ; 0.880 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 943 ; 1.448 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 889 ; 2.483 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 979 A 1286 REMARK 3 ORIGIN FOR THE GROUP (A): 17.1666 4.2602 46.3853 REMARK 3 T TENSOR REMARK 3 T11: 0.0012 T22: 0.0064 REMARK 3 T33: 0.0037 T12: -0.0021 REMARK 3 T13: 0.0013 T23: -0.0033 REMARK 3 L TENSOR REMARK 3 L11: 0.4988 L22: 0.5029 REMARK 3 L33: 0.4255 L12: -0.0729 REMARK 3 L13: 0.0759 L23: -0.1283 REMARK 3 S TENSOR REMARK 3 S11: -0.0159 S12: 0.0557 S13: -0.0247 REMARK 3 S21: 0.0019 S22: -0.0071 S23: 0.0101 REMARK 3 S31: -0.0011 S32: 0.0037 S33: 0.0230 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS THE SOLUBILIZING PART OF THE INHIBITOR, ATOMS C9, N10, REMARK 3 C11, C13, C14, O15, N16, C17 AND C18 ARE NOT OBSERVED IN THE REMARK 3 ELECTRON DENSITY. THEREFORE THEIR CONFORMATION IS OBSERVED REMARK 3 EXPERIMENTALLY AND REFLECTS AT BEST A LOWEST ENERGY CONFORMATION. REMARK 4 REMARK 4 5FXS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-MAR-16. REMARK 100 THE DEPOSITION ID IS D_1290066342. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25378 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.41000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.05500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.05500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.05500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.41000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.05500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 985 CG OD1 OD2 REMARK 470 GLU A 991 CD OE1 OE2 REMARK 470 GLU A 997 CG CD OE1 OE2 REMARK 470 LYS A 998 NZ REMARK 470 ARG A1003 NH1 NH2 REMARK 470 LYS A1023 CG CD CE NZ REMARK 470 ASP A1024 CG OD1 OD2 REMARK 470 GLU A1037 CD OE1 OE2 REMARK 470 GLU A1046 CD OE1 OE2 REMARK 470 GLU A1050 CD OE1 OE2 REMARK 470 GLU A1056 CD OE1 OE2 REMARK 470 MET A1098 CG SD CE REMARK 470 GLU A1099 CG CD OE1 OE2 REMARK 470 LYS A1111 NZ REMARK 470 ILE A1113 CD1 REMARK 470 LYS A1130 CD CE NZ REMARK 470 GLU A1145 CD OE1 OE2 REMARK 470 LYS A1168 CE NZ REMARK 470 LYS A1171 CG CD CE NZ REMARK 470 LYS A1185 CD CE NZ REMARK 470 GLN A1214 CD OE1 NE2 REMARK 470 GLU A1219 CD OE1 OE2 REMARK 470 ARG A1223 CD NE CZ NH1 NH2 REMARK 470 GLU A1227 CD OE1 OE2 REMARK 470 ASP A1235 CG OD1 OD2 REMARK 470 LYS A1254 CE NZ REMARK 470 GLU A1268 CG CD OE1 OE2 REMARK 470 GLU A1269 OE1 OE2 REMARK 470 GLU A1271 CD OE1 OE2 REMARK 470 ARG A1275 CG CD NE CZ NH1 NH2 REMARK 470 GLU A1276 CG CD OE1 OE2 REMARK 470 GLU A1284 CD OE1 OE2 REMARK 470 LYS A1286 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O MET A 1179 O HOH A 2209 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD1 ASN A 1101 O HOH A 2196 1455 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A1002 -92.38 -123.43 REMARK 500 MET A1098 46.90 -84.93 REMARK 500 ARG A1134 -11.09 79.12 REMARK 500 ASP A1135 46.47 -145.28 REMARK 500 TYR A1161 56.19 -93.96 REMARK 500 LYS A1171 -21.56 89.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2032 DISTANCE = 6.05 ANGSTROMS REMARK 525 HOH A2040 DISTANCE = 5.89 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 2287 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 2288 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 2289 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OZN A 2290 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FXQ RELATED DB: PDB REMARK 900 IGFR-1R COMPLEX WITH A PYRIMIDINE INHIBITOR. REMARK 900 RELATED ID: 5FXR RELATED DB: PDB REMARK 900 IGFR-1R COMPLEX WITH A PYRIMIDINE INHIBITOR. DBREF 5FXS A 980 1286 UNP P08069 IGF1R_HUMAN 980 1286 SEQADV 5FXS SER A 979 UNP P08069 EXPRESSION TAG SEQADV 5FXS ALA A 1159 UNP P08069 ASP 1159 CONFLICT SEQADV 5FXS GLU A 1211 UNP P08069 GLN 1211 CONFLICT SEQRES 1 A 308 SER TYR PHE SER ALA ALA ASP VAL TYR VAL PRO ASP GLU SEQRES 2 A 308 TRP GLU VAL ALA ARG GLU LYS ILE THR MET SER ARG GLU SEQRES 3 A 308 LEU GLY GLN GLY SER PHE GLY MET VAL TYR GLU GLY VAL SEQRES 4 A 308 ALA LYS GLY VAL VAL LYS ASP GLU PRO GLU THR ARG VAL SEQRES 5 A 308 ALA ILE LYS THR VAL ASN GLU ALA ALA SER MET ARG GLU SEQRES 6 A 308 ARG ILE GLU PHE LEU ASN GLU ALA SER VAL MET LYS GLU SEQRES 7 A 308 PHE ASN CYS HIS HIS VAL VAL ARG LEU LEU GLY VAL VAL SEQRES 8 A 308 SER GLN GLY GLN PRO THR LEU VAL ILE MET GLU LEU MET SEQRES 9 A 308 THR ARG GLY ASP LEU LYS SER TYR LEU ARG SER LEU ARG SEQRES 10 A 308 PRO GLU MET GLU ASN ASN PRO VAL LEU ALA PRO PRO SER SEQRES 11 A 308 LEU SER LYS MET ILE GLN MET ALA GLY GLU ILE ALA ASP SEQRES 12 A 308 GLY MET ALA TYR LEU ASN ALA ASN LYS PHE VAL HIS ARG SEQRES 13 A 308 ASP LEU ALA ALA ARG ASN CYS MET VAL ALA GLU ASP PHE SEQRES 14 A 308 THR VAL LYS ILE GLY ASP PHE GLY MET THR ARG ALA ILE SEQRES 15 A 308 TYR GLU THR ASP TYR TYR ARG LYS GLY GLY LYS GLY LEU SEQRES 16 A 308 LEU PRO VAL ARG TRP MET SER PRO GLU SER LEU LYS ASP SEQRES 17 A 308 GLY VAL PHE THR THR TYR SER ASP VAL TRP SER PHE GLY SEQRES 18 A 308 VAL VAL LEU TRP GLU ILE ALA THR LEU ALA GLU GLU PRO SEQRES 19 A 308 TYR GLN GLY LEU SER ASN GLU GLN VAL LEU ARG PHE VAL SEQRES 20 A 308 MET GLU GLY GLY LEU LEU ASP LYS PRO ASP ASN CYS PRO SEQRES 21 A 308 ASP MET LEU PHE GLU LEU MET ARG MET CYS TRP GLN TYR SEQRES 22 A 308 ASN PRO LYS MET ARG PRO SER PHE LEU GLU ILE ILE SER SEQRES 23 A 308 SER ILE LYS GLU GLU MET GLU PRO GLY PHE ARG GLU VAL SEQRES 24 A 308 SER PHE TYR TYR SER GLU GLU ASN LYS HET ACT A2287 4 HET ACT A2288 4 HET ACT A2289 4 HET OZN A2290 36 HETNAM ACT ACETATE ION HETNAM OZN 2-[4-[4-[[(6Z)-5-CHLORANYL-6-PYRAZOLO[1,5-A]PYRIDIN-3- HETNAM 2 OZN YLIDENE-1H-PYRIMIDIN-2-YL]AMINO]-3,5-DIMETHYL-PYRAZOL- HETNAM 3 OZN 1-YL]PIPERIDIN-1-YL]-N,N-DIMETHYL-ETHANAMIDE FORMUL 2 ACT 3(C2 H3 O2 1-) FORMUL 5 OZN C25 H31 CL N9 O FORMUL 6 HOH *274(H2 O) HELIX 1 1 ALA A 995 GLU A 997 5 3 HELIX 2 2 SER A 1040 SER A 1052 1 13 HELIX 3 3 VAL A 1053 PHE A 1057 5 5 HELIX 4 4 ASP A 1086 LEU A 1094 1 9 HELIX 5 5 SER A 1108 ASN A 1129 1 22 HELIX 6 6 ALA A 1137 ARG A 1139 5 3 HELIX 7 7 TYR A 1161 TYR A 1165 5 5 HELIX 8 8 PRO A 1175 MET A 1179 5 5 HELIX 9 9 SER A 1180 GLY A 1187 1 8 HELIX 10 10 THR A 1190 LEU A 1208 1 19 HELIX 11 11 SER A 1217 GLU A 1227 1 11 HELIX 12 12 PRO A 1238 TRP A 1249 1 12 HELIX 13 13 ASN A 1252 ARG A 1256 5 5 HELIX 14 14 SER A 1258 LYS A 1267 1 10 HELIX 15 15 GLU A 1268 MET A 1270 5 3 HELIX 16 16 GLY A 1273 SER A 1278 1 6 SHEET 1 AA 5 ILE A 999 GLN A1007 0 SHEET 2 AA 5 MET A1012 VAL A1022 -1 O VAL A1013 N LEU A1005 SHEET 3 AA 5 GLU A1025 VAL A1035 -1 O GLU A1025 N VAL A1022 SHEET 4 AA 5 THR A1075 GLU A1080 -1 O THR A1075 N VAL A1035 SHEET 5 AA 5 LEU A1065 VAL A1069 -1 N LEU A1066 O ILE A1078 SHEET 1 AB 2 CYS A1141 VAL A1143 0 SHEET 2 AB 2 VAL A1149 ILE A1151 -1 O LYS A1150 N MET A1142 SHEET 1 AC 2 TYR A1166 ARG A1167 0 SHEET 2 AC 2 LEU A1173 LEU A1174 -1 O LEU A1174 N TYR A1166 CISPEP 1 GLN A 1073 PRO A 1074 0 2.18 SITE 1 AC1 2 ARG A 996 LEU A1076 SITE 1 AC2 1 ARG A1084 SITE 1 AC3 3 ARG A1084 HOH A2124 OZN A2290 SITE 1 AC4 13 PHE A 981 SER A 982 LEU A1005 VAL A1013 SITE 2 AC4 13 ALA A1031 MET A1079 GLU A1080 MET A1082 SITE 3 AC4 13 GLY A1085 ASP A1153 MET A1156 HOH A2125 SITE 4 AC4 13 ACT A2289 CRYST1 40.820 66.110 122.110 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024498 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015126 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008189 0.00000